c-rel activates but v-rel suppresses transcription from kappa B sites

Proc Natl Acad Sci U S A. 1991 May 1;88(9):3715-9. doi: 10.1073/pnas.88.9.3715.

Abstract

We show that the product of the protooncogene c-rel is a constituent of an NF-kappa B-like complex that binds to the kappa B site originally identified in the enhancer of immunoglobulin kappa light chain gene. c-rel protein synthesized in bacteria binds to the kappa B site in a sequence-specific manner. The rel-kappa B complex can be disrupted by incubation with anti-rel antibodies. The rel protein can form oligomers. The c-rel protein can activate transcription from promoters containing kappa B sites; v-rel, on the other hand, suppresses the transcription of genes linked to kappa B sites. Thus, v-rel may interfere with the normal transcriptional machinery of the cell by acting as a dominant negative mutant.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Base Sequence
  • Binding Sites
  • Gene Expression Regulation*
  • In Vitro Techniques
  • Mice
  • Molecular Sequence Data
  • NF-kappa B / physiology*
  • Oncogene Proteins v-rel
  • Proto-Oncogene Proteins / physiology*
  • Proto-Oncogene Proteins c-rel
  • Recombinant Proteins
  • Regulatory Sequences, Nucleic Acid
  • Repressor Proteins / physiology
  • Retroviridae Proteins, Oncogenic / physiology*
  • Transcription Factors / physiology
  • Transcription, Genetic

Substances

  • NF-kappa B
  • Oncogene Proteins v-rel
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-rel
  • Recombinant Proteins
  • Repressor Proteins
  • Retroviridae Proteins, Oncogenic
  • Transcription Factors